Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.072 0.05
mRNA Doxorubicin gCSI pan-cancer AAC -0.1 0.05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.064 0.05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.071 0.05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.05
mRNA MST-312 CTRPv2 pan-cancer AAC 0.068 0.05
mRNA austocystin d CTRPv2 pan-cancer AAC 0.071 0.05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.072 0.05
Download CSV